CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM-2015 EXECUTIVE SUMMARY
Article
Garber, Alan J.; Abrahamson, Martin Julian; Barzilay, Joshua I.; Blonde, Lawrence; Bloomgarden, Zachary T.; Bush, Michael A.; Dagogo-Jack, Samuel; Davidson, Michael B.; Einhorn, Daniel; Garber, Jeffrey R.; Garvey, W. Timothy; Grunberger, George; Handelsman, Yehuda; Hirsch, Irl B.; Jellinger, Paul S.; McGill, Janet B.; Mechanick, Jeffrey I.; Rosenblit, Paul David; Umpierrez, Guillermo E.
Abstract
The 2015 algorithm for the comprehensive management of persons with type 2 diabetes (T2D) was developed to provide clinicians with a practical guide that considers the whole patient, the spectrum of risks and complications, and evidence-based approaches to treatment. In addition to advocating for glycemic control so as to reduce microvascular complications, this document focuses on obesity and prediabetes as the underlying risk factors for diabetes and associated macrovascular complications. It is now clear that the progressive beta-cell defect that drives the deterioration of metabolic control over time begins early and may be present before the diagnosis of diabetes (1).; This document accompanies the T2D Algorithm published in April 2015. It is organized into discrete sections that address the following topics: obesity; prediabetes; management of hyperglycemia through lifestyle modifications, pharmacotherapy, and insulin; management of hypertension; management of hyperlipidemia; and other riskreduction strategies.
